Literature DB >> 6310026

Characterization of extracellular alkaline proteases and collagenase induction in Vibrio alginolyticus.

P Hare, T Scott-Burden, D R Woods.   

Abstract

The number and approximate molecular weights of extracellular alkaline proteases produced by Vibrio alginolyticus were determined by gelatin-PAGE. Three major bands of protease activity with apparent molecular weights of approximately 28 000, 22 500 and 19 500 (proteases 1, 2 and 3, respectively) and two minor bands of protease activity with apparent molecular weights of approximately 15 500 and 14 500 (proteases 4 and 5, respectively) were obtained after gelatin-PAGE. The activities of the five proteases were inhibited by serine protease inhibitors but their activities were not affected by inhibitors of trypsin-like enzymes. Histidine, which inhibited V. alginolyticus collagenase, did not inhibit the activities of the alkaline serine proteases. The production of protease 1, however, was enhanced by histidine. Protease 1 production was also affected by temperature and production was depressed at 37 degrees C. Gelatin-PAGE of a commercial V. alginolyticus collagenase preparation revealed four bands of activity which were identified as collagenases with apparent molecular weights of approximately 45 000, 38 500, 33 500 and 31 000. The collagenase preparation was contaminated with two serine proteases. The release of [3H]proline from collagen matrices produced by smooth muscle cells was shown to be a sensitive assay for bacterial collagenases and was used to show that V. alginolyticus produced a basal constitutive level of extracellular collagenase. The constitutive levels of collagenase were affected by aeration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310026     DOI: 10.1099/00221287-129-4-1141

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  11 in total

1.  Nucleotide sequence of the Vibrio alginolyticus glnA region.

Authors:  R Maharaj; E Rumbak; W A Jones; S M Robb; F T Robb; D R Woods
Journal:  Arch Microbiol       Date:  1989       Impact factor: 2.552

2.  Intracranial infection by Vibrio alginolyticus following injury in salt water.

Authors:  S M Opal; J R Saxon
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

3.  Production and partial characterization of an elastolytic protease of Vibrio vulnificus.

Authors:  M H Kothary; A S Kreger
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Vibrio alginolyticus wound infection after exposure to sea water in an air crash.

Authors:  P Matsiota-Bernard; C Nauciel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

Review 5.  The human pathogenic vibrios--a public health update with environmental perspectives.

Authors:  P A West
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

6.  Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.

Authors:  G Ferry; J A Boutin; G Atassi; J L Fauchère; G C Tucker
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

Review 7.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Temperature and oxygen regulated expression of a glutamine synthetase gene from Vibrio alginolyticus cloned in Escherichia coli.

Authors:  R Maharaj; F T Robb; D R Woods
Journal:  Arch Microbiol       Date:  1986-10       Impact factor: 2.552

9.  Extracellular and surface-bound biological activities of Vibrio fluvialis, Vibrio furnissii and related species.

Authors:  D C Myatt; G H Davis
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

10.  Purification and regulation of glutamine synthetase in a collagenolytic Vibrio alginolyticus strain.

Authors:  S J Bodasing; P W Brandt; F T Robb; D R Woods
Journal:  Arch Microbiol       Date:  1985-01       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.